Cutinha D, Cini E. Be vigilant for depression in children and adolescents. Practitioner June 2018;262(1816):16-20
Be vigilant for depression in children and adolescents
25 Jun 2018
AUTHORS
Dr Darren Cutinha MA MSc MRCPsych, Consultant Child and Adolescent Psychiatrist, The Maudsley Centre for Child and Adolescent Eating Disorders, Honorary Senior Lecturer, University College London, London, UK
Dr Erica Cini MSc MD MRCPsych, Consultant Child and Adolescent Psychiatrist, East London Foundation Trust, Honorary Senior Clinical Lecturer, Imperial College, London, UK
Competing interests: None
Article
Abstract
The prevalence of depression is higher in adolescents (5.7%) than in children (2.8%) and this has remained stable over time. The 2:1 female to male ratio of depression in adults becomes evident in adolescents from the age of 12 years. The symptoms of depression in adolescents are similar to those in adults. Depression in children of primary school age may be very subtle and symptoms include mood fluctuations, tearfulness, frustration or temper tantrums. If depression is suspected, it is essential to evaluate the degree of risk. Risk has two key aspects: the likelihood of a potentially harmful incident occurring and degree of potential harm. Risk can change quickly and therefore needs to be evaluated regularly. A good risk assessment is therapeutic and will lower the pre-existing level of risk. The most important risk to evaluate is the risk an individual poses to him/herself either from self-harm or suicide. A risk assessment should include a safety plan i.e. steps to reduce the level of risk. Suicide is relatively rare in children and adolescents. Rates of completed suicide are approximately 4.8 deaths per 100,000 in the 10-19 year-old population and are higher in males than females. Those who have taken overdoses should be referred to A&E even if they have only taken small amounts of drugs e.g. six paracetamol tablets. This helps to convey a message that all overdoses are dangerous, is protective in case of under-reporting and should enable access to a review by CAMHS.
Adolescence is a high-risk period for the development of clinically significant, relatively common, mental health disorders such as depression.1
The prevalence of depression is higher in adolescents (5.7%) than children (2.8%) and this has remained stable over time.2 The female to male ratio for depression in adults is 2:1.3 This ratio is also seen in adolescents from the age of 12 years.4
In the UK, bipolar affective disorder is rarely diagnosed in individuals under the age of 18, especially in those under 13. It is more common in those who present with psychotic features, pharmacologically induced hypomania, psychomotor slowness or have a family history of bipolar disorder or psychosis.5
Diagnostic assessment
Teasing out the difference between the normal mood variations of adolescence, sub-threshold syndromes and anxiety and depressive disorders is vital.
Depression can be conceptualised as a spectrum, with threshold cases meeting specific criteria as identified in the ICD5 and DSM6 classification schemes for psychiatric disorder, see table 1. From these criteria it is clear that a child or adolescent may be clinically depressed without actually presenting with low mood.
It is important to ask about the presence or absence of particular symptoms: children and adolescents
will rarely share this information spontaneously, even if their symptoms are severe. It is also useful to consider risk factors for depression (see box 1) during the assessment.
The diagnosis of depression requires the presence of at least four5 or five6 symptoms that are present, most of the time, for most days for a minimum of two weeks. At least one of these must be a core symptom. These symptoms should be associated with significant distress and/or impairment of social or occupational functioning. Episodes of depression can be graded as mild, moderate, or severe depending on the number, type and intensity of symptoms.
The presentation of depression in adolescents can be similar to that in adults. Depression in primary school children may be very subtle and include mood fluctuations, increased irritability, tearfulness, frustration or temper tantrums. Somatic presentations such as abdominal pain or headaches are more common in younger children, who may struggle to express emotions verbally.7 Increased irritability, as a symptom of depression, is also common in this age group. This may be more marked in boys than girls. Delusions and suicide attempts are less common in children compared with adolescents.7
Differential diagnosis
Table 2 highlights the most common medical and psychiatric conditions in children and adolescents.
It is important to remember that the presence of one or more of these conditions does not necessarily exclude the possibility that the patient could have co-existing depression as well.
Coexisting conditions
Between 40 and 70% of children and adolescents presenting with a major depressive disorder, may also have other coexisting mental health conditions. These may include anxiety disorders, bipolar disorder, eating disorders, substance misuse and conduct disorder.8
Dysthymic disorder may increase the risk of children and young people developing a major depressive disorder.8 Personality is, however, continuing to develop throughout adolescence and into mid to late adulthood.9
Risk assessment
If you suspect that the patient may be depressed, it is essential to evaluate the degree to which they may be at risk. Risk has two key aspects: the likelihood of a potentially harmful incident occurring and the degree of potential harm. Risk is dynamic and can change quickly. Therefore, risk needs to be evaluated regularly.
The term risk assessment is somewhat of a misnomer: a good risk assessment will also be therapeutic and lower the pre-existing level of risk. Risk assessments therefore represent a bridge between assessment and management.
The therapeutic relationship is important in improving health outcomes.10 Compassion, warmth, sensitivity and patience are common factors in clinical encounters that have been shown to be associated with better outcomes. These factors are particularly important during risk assessments to make them therapeutic and effective.
There are four main areas of risk: risk to self, to others, from others, to property. The most important risk to evaluate in children and adolescents with depression is the risk the patient poses to him/herself either from self-harm or suicide.
A good risk assessment will also include a safety plan, i.e. steps to reduce the level of risk e.g. informing parents, parents locking away medications or sharp objects, referral to child and adolescent mental health services (CAMHS) or A&E.
It is important to remember that asking about thoughts of suicide or self-harm does not lead to an increase in the likelihood of either occurring.11
Self-harm and suicide
Self-harm is very common in children and adolescents12 and rates are increasing.13 Self-harm may occur in a range of conditions - and on its own does not necessarily mean that the individual is clinically depressed. Frequent methods of self-harming include scratching, cutting, hitting/punching, head banging, taking less care (e.g. when crossing the road or going out alone late at night), placing oneself in vulnerable situations, overdoses with non-suicidal intent. Although the intention may ‘only’ be self-harm, individuals may unintentionally be at risk of fatal injury e.g. by cutting deeper than expected.
There are many reasons for self-harm – communicating distress, relief, self-punishment, a desire to ‘feel’ if numb, conversion of emotional to physical pain which may be experienced as more real or manageable.12,14 The associated level of risk may depend on several factors: the method of self-harming, the degree of physical harm/damage caused, e.g. depth and location of cuts, frequency, duration, intention (relief of distress, or self-punishment).
Suicide is relatively rare in children and adolescents. Rates of completed suicide are approximately 4.8 deaths per 100,000 in the 10-19 year age group and are higher in males than females.15 A recent study found that the incidence of suicide in adolescent boys is more than twice that among adolescent girls, whereas self-harm is much more common in girls than boys.16 The most dangerous acts associated with suicidal thoughts, are an intention to jump (from buildings/in front of cars/trains); hanging/asphyxiation, and shooting. The risk of suicide is significantly increased in those who self-harm.12
All individuals who have taken overdoses should be referred to A&E. This includes those who may have taken relatively small amounts of drugs e.g. six paracetamol tablets. This helps to convey a message that all overdoses are dangerous, it is protective in case of under-reporting and it should enable access to a review by CAMHS.
NICE guidelines for self-harm recommend that all young people who present to A&E with self-harm or following an overdose should be admitted to a paediatric ward overnight.17 This facilitates a CAMHS review, and increases the likelihood that it will be useful. The patient may feel more rested and able to talk the next day. Hospitals may also routinely make a social services referral following presentations of self-harm. This is because self-harm may signal a range of wider difficulties or distress.
Intent and protective factors
When considering the risks associated with self-harm and suicide it is important to differentiate between thoughts, intent and plans. Thoughts represent the lowest level of risk; intent, intermediate; and plans/completed acts, the highest. For example, thoughts of suicide are a symptom of depression. The associated risks may be low if the individual also says that they have no intention of acting on them, and have not made any plans to do so, they would not commit suicide because they would be concerned about the effect on their family and friends and/or for religious reasons. Thoughts of suicide, associated with a stated lack of intent and no associated significant recent previous attempts or plans, is not an emergency and these individuals do not need to be referred to A&E.
The nature of intent and any recent acts is also important to consider.
The relationship between intent and acts in relation to risk is not always straightforward. For example, self-harm that is associated with superficial scratches (completed act), is a lower risk than an intention to self-harm by severing an artery (act not yet taken place, although appears likely).
Protective factors reduce the level of risk and should always be explored. These may be effective coping strategies, hope, good relationships with family/friends, positive future plans.
Key questions for risk assessment of self-harm and suicide are listed in box 2.
Key questions following an overdose are listed in box 3.
Confidentiality and safety plans
If you conclude that a child or adolescent is at significant risk then a parent or other responsible adult should be informed. Breaching confidentiality in this situation is justified if you cannot get consent for information sharing. Relatively minor levels of self-harm e.g. superficial cutting, may not necessarily need to be shared with parents in the short term, if it can be used to build a therapeutic alliance that may lead to engagement with a plan for treatment e.g. referral to CAMHS.
Safety plans that involve parents can significantly help to reduce levels of risk. Parents may be able to reduce access to potentially harmful objects and be able to provide comfort and support.
Where relationships with parents are not caring or supportive, and the child is at significant risk, then consideration should be given to informing an alternative responsible adult and/or social services.
In emergency situations, a child or adolescent should not be expected to go to A&E alone. An adult from the practice should wait with them, until a responsible adult can come to collect them.
Management
GPs have a key role in recognition of depression, early referral and risk assessment. This includes:19
• Referral to CAMHS or to A&E in an emergency (e.g. overdose or strong and imminent suicidal intent)
• Risk assessment for suspected/known cases
• Treatment of any self-harm if indicated e.g. suturing deep cuts, prescribing antibiotics if wounds become infected
• Shared care arrangements with CAMHS where GPs are continuing to prescribe and monitor the response
to medications that have been initiated by specialists
GPs would generally be expected to play a very limited role in all other aspects of the management of depression in children and adolescents.
The NICE guideline on depression in children and adolescents19 provides guidance about the roles of primary care, when to refer and treatment options available.
Referral
The following cases should be referred to CAMHS19
• Active suicidal ideas or plans
• Referral requested by patient, parents or carers
• Diagnosis of moderate/severe depression or mild depression that has not responded to treatment in primary care
• Unexplained self-neglect of at least one month’s duration that could be harmful to physical health
NICE stepped care model of treatment
Treatment of depression varies depending on the severity of the symptoms. Depression should be treated in CAMHS unless the episode is mild and of less than three months’ duration. For mild depression, NICE recommends initial management should be watchful waiting, followed by a review of mental state after two weeks.19 If there is no response, then individual non-directive supportive therapy, guided self-help or group CBT should be offered. These could be provided by appropriately trained professionals in primary care, schools, social services, the voluntary sector or Tier 2 CAMHS. In their absence a referral to Tier 3 CAMHS would be appropriate.
NICE recommends Tier 3/4 CAMHS should treat moderate to severe depression, and mild depression unresponsive to treatment and/or of more than three months’ duration.
The following treatments are recommended for moderate to severe depression: individual CBT, family therapy, interpersonal therapy or psychodynamic psychotherapy.
These may be started initially alone, or in combination with fluoxetine.
Prescribing antidepressants
NICE recommends that antidepressants should not be initiated in general practice for children and adolescents with depression or anxiety without advice from CAMHS. We would also advise that propranolol is not prescribed for anxiety. Although propranolol can relieve some troublesome anxiety symptoms, it is much less effective in helping with the associated underlying thoughts and emotions than antidepressants prescribed for anxiety.
NICE also recommends that CAMHS should only prescribe antidepressants in combination with psychological treatments,19 although a meta-analysis20 has questioned this. Antidepressants should not be prescribed for mild depression.
Fluoxetine is the first-line medication recommended by NICE.19 In the most recent large meta-analysis, fluoxetine was the only antidepressant shown to be more effective than placebo in children and adolescents.21 Second-line medications include sertraline and citalopram.19 Paroxetine, venlafaxine and tricyclic antidepressants are not recommended for the treatment of depression in this age group. These medications are associated with higher risks of suicide and are more dangerous in overdose.19
On initiation of the antidepressant, CAMHS should undertake a regular review of monitoring for any adverse effects, and response to the medication, and a mental state examination should be undertaken weekly for the first four weeks.19 This time period is key, as 40% of suicide attempts occur within this timeframe.22
Monitoring and stopping antidepressants
CAMHS may commonly discharge young people on antidepressants after psychological treatment is finished and they are doing well. If they do, CAMHS should also provide guidance for GPs regarding monitoring of antidepressants and how and when to stop prescribing.
Antidepressants should usually only be stopped after a patient is symptom free for six months after a first episode of depression, or two years if there have been several episodes. This is to reduce the risk of relapse.
The dose of antidepressants should be reduced gradually. Suddenly stopping antidepressants can lead to discontinuation symptoms.23
Outcomes and prognosis
Outcome is dependent on the age of onset. Adolescent depression is associated with a 60-90% remission rate within one year, with 50-70% of young adolescents suffering a relapse within five years.24,25 Both childhood and adolescent onset depression are likely to recur with a 40% probability of recurrence at two years and 70% by five years.26
Shorter duration of illness is associated with a better prognosis. Female gender and parental separation or divorce are associated with a worse prognosis.1 In females, first episode depression is associated with lower levels of impairment and suicide attempts.4 There is no difference in number of suicide attempts in males with a first episode or recurrent episodes of depression.4
A long duration of illness is a predictor for continuation of the illness into adulthood.1 Unlike adolescent-onset depression, childhood depression does not necessarily lead to depression in adulthood.27
REFERENCES
1 Patton GC, Coffey C, Romaniuk H et al. The prognosis of common mental disorders in adolescents: a 14-year prospective cohort study. Lancet 2014;383:1404-11
2 Costello EJ, Erkanli A, Angold A. Is there an epidemic of child or adolescent depression? J Child Psychol Psychiatry 2006;47(12):1263-71
3 Martin LA, Neighbors HW, Griffith DM. The experience of symptoms of depression in men vs women analysis of the national comorbidity survey replication. JAMA Psychiatry 2013;70(10):1100-06
4 Breslau J, Gilman SE, Stein BD et al. Sex differences in recent first-onset depression in an epidemiological sample of adolescents. Transl Psychiatry 2017;7:e1139
5 World Health Organization. 1992. The International Classification of Mental and Behavioural Disorders. ISBN: 92-4-154422-8
6 American Psychiatric Association. 2013. DSM-V. 5th Edition. ISBN: 978-0-89042-554-1
7 Birmaher B, Brent D, Bernet W et al. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry 2007;46(11):1503-26
8 Birmaher B, Ryan ND, Williamson DE et al. Childhood and adolescent depression: a review of the past ten years. Part I. J Am Acad Child Adolesc Psychiatry 1996; 35(11):1427-39
9 Costa PT, McCrae RR. Stability and change in personality from adolescence through adulthood. In Halverson CF, Kohnstamm GA, Martin RP (eds). The developing structure of temperament and personality from infancy to adulthood. Lawrence Erlbaum Associates Inc. Hillsdale, NJ, US. 1994
10 Kelley JM, Kraft-Todd G, Schapira L et al. The Influence of the patient-clinician relationship on healthcare outcomes: A systematic review and meta-analysis of randomized controlled trials PLoS One 2014;9(4):e94207
11 Dazzi T, Gribble R, Wessely S, Fear NT. Does asking about suicide and related behaviours induce suicidal ideation? What is the evidence? Psychol Med 2014;44(16):3361-63
12 Hawton K, Saunders KE, O'Connor RC. Self-harm and suicide in adolescents. Lancet 2012; 23:379(9834):2373-82
13 Morgan C, Webb RT, Carr MJ et al. Incidence, clinical management, and mortality risk following self harm among children and adolescents: cohort study in primary care. BMJ 2017;359:j4351
14 Edmondson AJ, Brennan CA, House AO. Non-suicidal reasons for self-harm: A systematic review of self-reported accounts. J Affect Disord 2016;191:109-17
15 The National Confidential Inquiry into Suicide and Homicide by People with Mental Illness. Annual Report: England, Northern Ireland, Scotland and Wales. University of Manchester. 2017
16 Geulayov G, Casey D, McDonald KC et al. Incidence of suicide, hospital-presenting non-fatal self-harm, and community-occurring non-fatal self-harm in adolescents in England (the iceberg model of self-harm):a retrospective study. Lancet Psychiatry 2018;5:67-74
17 National Institute for Health and Care Excellence. QS24. Self-harm. NICE. London. 2013 www.nice.org.uk/guidance/qs34
18 Kingsbury S. PATHOS: A screening instrument for adolescent overdose: A research note. J Child Psychol Psychiat 1996;37(5):609-11
19 National Institute for Health and Care Excellence. CG28. Depression in children and young people: identification and management. NICE. London. 2005 updated 2015. www.nice.org.uk/guidance/cg28
20 Dubicka B, Elvins R, Roberts C et al. Combined treatment with cognitive behavioural therapy in adolescent depression: meta-analysis. BJPsych Open 2010;197:433-40
21 Cipriani A, Zhou X, Del Giovane C et al. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: A network meta-analysis. Lancet 2016;388:881-90
22 Brent DA, Greenhill LL, Compton S et al. The treatment of adolescent suicide attempters study (TASA): Predictors of suicidal events in an open treatment trial. J Am Acad Child Adolesc Psychiatry 2009;48:987-96
23 Haddad P, Lejoyeux M, Young A. Stopping antidepressants can lead to discontinuation symptoms. BMJ 1998; 316(7138):1105-06
24 Dunn V, Goodyer IA. Longitudinal investigation into childhood- and adolescence-onset depression: psychiatric outcome in early adulthood. Br J Psychiatry 2006;188:216-22
25 Lewinsohn PM, Rohde P, Seeley JR et al. Natural course of adolescent major depressive disorder in a community sample: Predictors of recurrence in young adults. Am J Psychiatry 2000;157:1584-91
26 Rao U, Chen L. Characteristics, correlates, and outcomes of childhood and adolescent depressive disorders. Dialogues Clin Neurosci 2009;11(1):45-62
27 Harrington R, Fudge H, Rutter M et al. Adult outcomes of childhood and adolescent depression. I. Psychiatric status. Arch Gen Psychiatry 1990;47:465-73
ARTICLE IN PDF
EXTERNAL WEBLINKS
Royal College of Psychiatrists
Information leaflets for patients and their families on depression and the management options. There is also a useful link that outlines who’s who in CAMHS
A free downloadable app for children and young people to help improve their coping skills
An app which includes a mood tracker as well as CBT-based techniques to help with managing depressive symptoms

